APA (7th ed.) Citation

TC, F., TH, H., CT, Y., PT, L., NC, C., TC, L., . . . AL, Y. (2026). Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII, 75(5), . https://doi.org/10.1007/s00262-026-04388-x

Chicago Style (17th ed.) Citation

TC, Fan, Hung TH, Yeh CT, Lin PT, Chang NC, Lo TC, Wu TJ, Yu J, and Yu AL. "Targeting ST3GAL1 to Downregulate Ligands for the Glycoimmune Checkpoint Siglec-7 and Reverse Immune Escape in Hepatocellular Carcinoma." Cancer Immunology, Immunotherapy : CII 75, no. 5 (2026). https://doi.org/10.1007/s00262-026-04388-x.

MLA (9th ed.) Citation

TC, Fan, et al. "Targeting ST3GAL1 to Downregulate Ligands for the Glycoimmune Checkpoint Siglec-7 and Reverse Immune Escape in Hepatocellular Carcinoma." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 5, 2026, https://doi.org/10.1007/s00262-026-04388-x.